On Friday 18 September, the European Commission confirmed that it will be participating in the COVAX facility, an initiative for equitable access to affordable Covid-19 vaccines worldwide that is operating under the aegis of GAVI (the Vaccine Alliance), CEPI and WHO.
At the same time, it also set out the source of the €400 million in guarantees which, on 31 August, it announced it intended to mobilise for this purpose (see EUROPE B12549A3).
The EU, its Member States and the European...